During the period of COVID-19, HLJDD was also found to play a therapeutic role in COVID-19 through regulating multiple signaling pathways based on targeting genes such as IL6, IL10, MMP9, NOS2, VEGF, and TGFβ1 (Liu et al., 2021). This evidence concerns the gene IL10 and COVID-19.